Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 7
1998 2
2000 1
2001 2
2002 3
2003 3
2004 3
2005 3
2006 2
2007 1
2009 1
2010 4
2011 2
2012 4
2013 3
2014 10
2015 5
2016 4
2017 12
2018 14
2019 17
2020 14
2021 16
2022 16
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Inflammatory myopathies: an update for neurologists.
Silva AMS, Campos ED, Zanoteli E. Silva AMS, et al. Among authors: zanoteli e. Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):238-248. doi: 10.1590/0004-282X-ANP-2022-S131. Arq Neuropsiquiatr. 2022. PMID: 35976321 Free PMC article. Review.
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls.
Darras BT, Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Xiong H, Zanoteli E, Baranello G, Bruno C, Vlodavets D, Wang Y, El-Khairi M, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Fontoura P, Servais L; FIREFISH Working Group. Darras BT, et al. Among authors: zanoteli e. N Engl J Med. 2021 Jul 29;385(5):427-435. doi: 10.1056/NEJMoa2102047. N Engl J Med. 2021. PMID: 34320287
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.
Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Servais L, Xiong H, Zanoteli E, Baranello G, Bruno C, Day JW, Deconinck N, Klein A, Mercuri E, Vlodavets D, Wang Y, Dodman A, El-Khairi M, Gorni K, Jaber B, Kletzl H, Gaki E, Fontoura P, Darras BT; FIREFISH Study Group. Masson R, et al. Among authors: zanoteli e. Lancet Neurol. 2022 Dec;21(12):1110-1119. doi: 10.1016/S1474-4422(22)00339-8. Epub 2022 Oct 14. Lancet Neurol. 2022. PMID: 36244364 Clinical Trial.
Gene therapy in neuromuscular disorders.
Mendonça RH, Zanoteli E. Mendonça RH, et al. Among authors: zanoteli e. Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):249-256. doi: 10.1590/0004-282X-ANP-2022-S135. Arq Neuropsiquiatr. 2022. PMID: 35976325 Free PMC article. Review.
Rhabdomyolysis: a genetic perspective.
Scalco RS, Gardiner AR, Pitceathly RD, Zanoteli E, Becker J, Holton JL, Houlden H, Jungbluth H, Quinlivan R. Scalco RS, et al. Among authors: zanoteli e. Orphanet J Rare Dis. 2015 May 2;10:51. doi: 10.1186/s13023-015-0264-3. Orphanet J Rare Dis. 2015. PMID: 25929793 Free PMC article. Review.
Therapeutic advances in 5q-linked spinal muscular atrophy.
Reed UC, Zanoteli E. Reed UC, et al. Among authors: zanoteli e. Arq Neuropsiquiatr. 2018 Apr;76(4):265-272. doi: 10.1590/0004-282x20180011. Arq Neuropsiquiatr. 2018. PMID: 29742241 Free article. Review.
Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study.
Schiava M, Ikenaga C, Villar-Quiles RN, Caballero-Ávila M, Topf A, Nishino I, Kimonis V, Udd B, Schoser B, Zanoteli E, Souza PVS, Tasca G, Lloyd T, Lopez-de Munain A, Paradas C, Pegoraro E, Nadaj-Pakleza A, De Bleecker J, Badrising U, Alonso-Jiménez A, Kostera-Pruszczyk A, Miralles F, Shin JH, Bevilacqua JA, Olivé M, Vorgerd M, Kley R, Brady S, Williams T, Domínguez-González C, Papadimas GK, Warman-Chardon J, Claeys KG, de Visser M, Muelas N, LaForet P, Malfatti E, Alfano LN, Nair SS, Manousakis G, Kushlaf HA, Harms MB, Nance C, Ramos-Fransi A, Rodolico C, Hewamadduma C, Cetin H, García-García J, Pál E, Farrugia ME, Lamont PJ, Quinn C, Nedkova-Hristova V, Peric S, Luo S, Oldfors A, Taylor K, Ralston S, Stojkovic T, Weihl C, Diaz-Manera J; VCP International Study Group; VCP International Study Group. Schiava M, et al. Among authors: zanoteli e. J Neurol Neurosurg Psychiatry. 2022 Jul 27:jnnp-2022-328921. doi: 10.1136/jnnp-2022-328921. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 35896379 Free PMC article.
Juvenile Gerstmann-Sträussler-Scheinker Disease Mimicking Anticipation Phenomenon.
Yoshinaga Tonholo Silva T, Oliveira Marques MV, Zanoteli E, Pedroso JL, Graziani Povoas Barsottini O. Yoshinaga Tonholo Silva T, et al. Among authors: zanoteli e. Mov Disord Clin Pract. 2023 Sep 15;10(11):1700-1702. doi: 10.1002/mdc3.13878. eCollection 2023 Nov. Mov Disord Clin Pract. 2023. PMID: 37982114 No abstract available.
Severe progressive brain involvement in a patient with TRMT10C mutation.
Camelo CG, Silva AMS, Rocha AJ, Scaramuzzi V, Moreno CAM, Reed UC, Zanoteli E. Camelo CG, et al. Among authors: zanoteli e. Arq Neuropsiquiatr. 2021 Mar;79(3):259-260. doi: 10.1590/0004-282X-ANP-2020-0355. Arq Neuropsiquiatr. 2021. PMID: 33886802 Free article. No abstract available.
Gene-based therapies for neuromuscular disorders.
Zanoteli E, França MC Jr, Marques W Jr. Zanoteli E, et al. Arq Neuropsiquiatr. 2024 Jun;82(6):1-10. doi: 10.1055/s-0043-1777755. Epub 2024 Feb 7. Arq Neuropsiquiatr. 2024. PMID: 38325390 Free PMC article.
153 results